Updated Jul 16, 2026 · Last SEC filing 2026-06-05
Denali Therapeutics Inc. (DNLI) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-05. 5 Form 8-K material event filings were reported by DNLI in the last 90 days. InsiderAlpha tracks every DNLI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001714899 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Latest Form 4 filing | 2026-06-05 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| FLATLEY JAY T | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| BAKER BROS. ADVISORS LP | Insider | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Thornberry Nancy | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Cook Jennifer E. | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Van Hauwermeiren Timothy | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| BAKER BROS. ADVISORS LP | Insider | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Klein Peter S | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Schenkein David P | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Watts Ryan J. | President and CEO | G — Bona-fide gift | 50.0K | $0.00 | — | SEC | |
| Ho Carole | Chief Medical Officer | S — Open-market sale | 806 | $14.64 | $12K | SEC | |
| Ho Carole | Chief Medical Officer | S — Open-market sale | 2.9K | $13.58 | $40K | SEC | |
| Schuth Alexander O. | COFO and Secretary | S — Open-market sale | 2.9K | $13.58 | $40K | SEC | |
| Ho Carole | Chief Medical Officer | M — Option exercise | 44.7K | $0.68 | $30K | SEC | |
| Watts Ryan J. | President and CEO | S — Open-market sale | 495.3K | $15.00 | $7.43M | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Denali Therapeutics Inc. (DNLI). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| BAKER BROS. ADVISORS LP | 4 | — |
| Krognes Steve E. | 2 | — |
| Cook Jennifer E. | 2 | — |
| Schenkein David P | 2 | — |
| FLATLEY JAY T | 2 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in DNLI insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live DNLI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.